Arkolith/Insider Trading/CTXR/Form 4

Webb Carol

DirectorCitius Pharmaceuticals, Inc. (CTXR) · full profile →Form 4 · filed Aug 30, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 4, 2024Option exercise(M)12K$0.02$24112K
Mar 4, 2024Tax withholding(F)236$0.77$18212K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 4, 2024Option exercise(M)12K—$00

Transaction Codes

M
Option exercise / conversion
F
Shares withheld for taxes

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001213900-24-074505) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML